
Sign up to save your podcasts
Or


Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing
By This Week in Hearing5
11 ratings
Biotechnology and pharmaceutical companies are increasingly investing in the development for therapeutics for hearing disorders. In this episode, Dr. Brian Taylor sits down with Celia Belline, CEO of CILCare and Peter Markham, CEO of CBSET, to discuss the future of pharmaceuticals and regenerative medicine in the identification and treatment of hearing disorders.
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
https://www.linkedin.com/company/this-week-in-hearing/
https://twitter.com/WeekinHearing

38,460 Listeners

9,483 Listeners

30,274 Listeners

87,149 Listeners

112,489 Listeners

24,692 Listeners

8,530 Listeners

5,446 Listeners

20 Listeners

58,262 Listeners

166 Listeners

1,058 Listeners